Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
39.68
-1.53 (-3.71%)
At close: Jan 2, 2026, 4:00 PM EST
39.97
+0.29 (0.73%)
After-hours: Jan 2, 2026, 7:25 PM EST
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $1.7 billion as of January 2, 2026. Its market cap has increased by 139.21% in one year.
Market Cap
1.70B
Enterprise Value
1.15B
1-Year Change
139.21%
Ranking
Category
Stock Price
$39.68
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $1.70B, an increase of 943.79%. That is a compound annual growth rate of 176.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 1.70B | -3.71% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.63B |
| Johnson & Johnson | 497.83B |
| AbbVie | 404.73B |
| UnitedHealth Group | 299.98B |
| AstraZeneca | 288.12B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.95B |
| Novo Nordisk | 227.63B |